Annual EBITDA
$7.76B$7.04B-47.54%
Summary
- Current Value
- As of today, AMGN annual EBITDA is $7.76B, down -47.54% on
- Historical Performance
- AMGN annual EBITDA is down -31.27% over the past 3 years, and down -38.54% over the past 5 years
- All-Time High Comparison
- AMGN annual EBITDA is currently -47.54% below its historical high of $14.80B set on
- 3-Year Low Comparison
- AMGN annual EBITDA is at its 3-year low
- Sector Comparison
- AMGN annual EBITDA is higher than 98.30% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $7.76B | -47.5% | -31.3% | -38.5% | +13.7% | |
| Quarterly EBITDA | $3.86B | +13.6% | +11.7% | +16.5% | +127.0% | |
| TTM EBITDA | $15.68B | +29.8% | +21.9% | +26.4% | +138.3% | |
| Price | $328.97 | +24.5% | +21.8% | +37.9% | +477.3% | |
| PE Ratio | 25.43 | -27.4% | +14.0% | +31.3% | +113.7% | |
| Annual Revenue | $33.23B | +18.6% | +27.9% | +42.9% | +126.9% | |
| Annual EPS | $7.56 | -39.5% | -26.5% | -41.3% | +67.6% | |
| Annual EBIT | $7.76B | -27.6% | -1.7% | -25.5% | +34.3% | |
| Annual Net Income | $4.09B | -39.1% | -30.6% | -47.8% | -11.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $14.80B | -47.5% | |
| 5Y | $14.80B | -47.5% | |
| All | $14.80B | -47.5% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $7.76B | at low | |
| 5Y | $7.76B | at low | |
| All | -$8.50M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of AMGN?
As of today, AMGN annual EBITDA is $7.76B
What is 1-year change in AMGN annual EBITDA?
AMGN annual EBITDA is down -47.54% year-over-year
What is 3-year change in AMGN annual EBITDA?
AMGN annual EBITDA is down -31.27% over the past 3 years
How far is AMGN annual EBITDA from its all-time high?
AMGN annual EBITDA is currently -47.54% below its historical high of $14.80B set on December 31, 2023
How does AMGN annual EBITDA rank versus sector peers?
AMGN annual EBITDA is higher than 98.30% of companies in Healthcare sector
When is AMGN next annual earnings release?
The next annual earnings release for AMGN is on
Quarterly EBITDA
$3.86B$124.00M-3.11%
Summary
- Current Value
- As of today, AMGN quarterly EBITDA is $3.86B, down -3.11% on
- Historical Performance
- AMGN quarterly EBITDA is up +13.63% year-over-year, and up +11.72% over the past 3 years
- All-Time High Comparison
- AMGN quarterly EBITDA is currently -27.53% below its historical high of $5.33B set on
- 3-Year Low Comparison
- AMGN quarterly EBITDA is +65.07% above its 3-year low of $2.34B reached on
- Sector Comparison
- AMGN quarterly EBITDA is higher than 98.74% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $3.86B | -3.1% | +13.6% | +11.7% | +16.5% | |
| Annual EBITDA | $7.76B | – | -47.5% | -31.3% | -38.5% | |
| TTM EBITDA | $15.68B | +3.0% | +29.8% | +21.9% | +26.4% | |
| Price | $328.97 | +11.3% | +24.5% | +21.8% | +37.9% | |
| PE Ratio | 25.43 | +11.3% | -27.4% | +14.0% | +31.3% | |
| Quarterly Revenue | $9.59B | +4.6% | +13.3% | +45.6% | +50.2% | |
| Quarterly EPS | $5.93 | +124.2% | +13.6% | +49.0% | +72.9% | |
| Quarterly EBIT | $3.98B | +50.4% | +98.6% | +53.5% | +64.8% | |
| Quarterly Net Income | $3.22B | +124.6% | +13.6% | +50.1% | +59.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.33B | N/A | -27.5% |
| 3Y | $5.33B | -27.5% | |
| 5Y | $5.33B | -27.5% | |
| All | $5.33B | -27.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.51B | +53.9% | |
| 3Y | $2.34B | +65.1% | |
| 5Y | $2.34B | +65.1% | |
| All | -$68.80M | +5711.9% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of AMGN?
As of today, AMGN quarterly EBITDA is $3.86B
What is AMGN quarterly EBITDA most recent change?
AMGN quarterly EBITDA was down -3.11% on September 30, 2025
What is 1-year change in AMGN quarterly EBITDA?
AMGN quarterly EBITDA is up +13.63% year-over-year
How far is AMGN quarterly EBITDA from its all-time high?
AMGN quarterly EBITDA is currently -27.53% below its historical high of $5.33B set on December 31, 2024
How does AMGN quarterly EBITDA rank versus sector peers?
AMGN quarterly EBITDA is higher than 98.74% of companies in Healthcare sector
When is AMGN next earnings release?
The next earnings release for AMGN is on
TTM EBITDA
$15.68B$463.00M+3.04%
Summary
- Current Value
- As of today, AMGN TTM EBITDA is $15.68B, up +3.04% on
- Historical Performance
- AMGN TTM EBITDA is up +29.77% year-over-year, and up +21.94% over the past 3 years
- All-Time High Comparison
- AMGN TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- AMGN TTM EBITDA is +35.55% above its 3-year low of $11.57B reached on
- Sector Comparison
- AMGN TTM EBITDA is higher than 99.01% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $15.68B | +3.0% | +29.8% | +21.9% | +26.4% | |
| Annual EBITDA | $7.76B | – | -47.5% | -31.3% | -38.5% | |
| Quarterly EBITDA | $3.86B | -3.1% | +13.6% | +11.7% | +16.5% | |
| Price | $328.97 | +11.3% | +24.5% | +21.8% | +37.9% | |
| PE Ratio | 25.43 | +11.3% | -27.4% | +14.0% | +31.3% | |
| TTM Revenue | $35.89B | +3.2% | +11.0% | +37.2% | +44.8% | |
| TTM EPS | $12.94 | +5.8% | +65.6% | +3.7% | +4.3% | |
| TTM EBIT | $11.67B | +20.4% | +79.3% | +23.2% | +30.0% | |
| TTM Net Income | $7.01B | +5.8% | +65.6% | +2.5% | -4.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $15.68B | at high | |
| 3Y | $15.68B | at high | |
| 5Y | $15.68B | at high | |
| All | $15.68B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $14.32B | N/A | +9.5% |
| 3Y | $11.57B | +35.5% | |
| 5Y | $11.57B | +35.5% | |
| All | -$36.20M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of AMGN?
As of today, AMGN TTM EBITDA is $15.68B
What is AMGN TTM EBITDA most recent change?
AMGN TTM EBITDA was up +3.04% on September 30, 2025
What is 1-year change in AMGN TTM EBITDA?
AMGN TTM EBITDA is up +29.77% year-over-year
How far is AMGN TTM EBITDA from its all-time high?
AMGN TTM EBITDA is currently at its all-time high
How does AMGN TTM EBITDA rank versus sector peers?
AMGN TTM EBITDA is higher than 99.01% of companies in Healthcare sector
When is AMGN next earnings release?
The next earnings release for AMGN is on
EBITDA Formula
Data Sources & References
- AMGN Official Website www.amgen.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/318154/000031815425000072/0000318154-25-000072-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/318154/000031815425000010/0000318154-25-000010-index.htm
- AMGN Profile on Yahoo Finance finance.yahoo.com/quote/AMGN
- AMGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amgn